Dr. Candès's research interests are in computational harmonic analysis, statistics, information theory, signal processing and mathematical optimization with applications to the imaging sciences, scientific computing and inverse problems.

The Stanford Computational Imaging Group, led by Dr. Wetzstein, develops next-generation computational imaging and display systems.

Dr. Ré's group works on the fundamentals of the next generation of data management systems, including databases, theory, and machine learning.

Dr. Pianetta's research is directed towards understanding how the atomic and electronic structure of semiconductor interfaces impacts device technology.

Dr. Holodniy's research program is currently focused in three areas: translational research, HIV/HCV clinical trials, and health services research focusing on cost effectiveness of HIV antibody and ARV resistance testing and ARV utilization and clinical outcome.

Work in the Vollrath laboratory is focused on understanding processes in the eye that are relevant to human health and disease.

Dr. Kenneth Weinberg's laboratory's efforts are aimed at understanding the reciprocal interactions between immature T lymphocytes (“thymocytes”) and thymic epithelial cells, the stromal cells of the thymus which support T lymphocyte development. Such interactions are abnormal in both genetic diseases of children like severe combined immune deficiency (SCID) and the DiGeorge syndrome, and in aging and autoimmune diseases.

Dr. Hadly uses a combined field and laboratory approach to examine how ecological perturbations link or decouple levels of biological organization, because understanding the links among ecosystems, species, populations and genes is central to understanding how organisms exist, evolve and become extinct.

The Stanford Cardiac Surgical Arrhythmia Research Laboratory is a multidisciplinary, translational and basic science research laboratory that focuses on understanding the underlying electrophysiologic mechanisms of atrial fibrillation and translating this understanding into potential therapies for the treatment of atrial fibrillation.

Dr. Barna's lab studies how intricate control of gene expression and cell signaling is regulated on a minute-by-minute basis to give rise to the remarkable diversity of cell types and tissue morphology that form the living blueprints of developing organisms.